The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 354:203-205 January 12, 2006 Number 2
NextNext

Azithromycin versus Penicillin for Early Syphilis

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Holmes, K. K.
-Related Article
by Riedner, G.
-PubMed Citation
To the Editor: In their study on the treatment of early syphilis, Riedner et al. (Sept. 22 issue)1 concluded that the wider use of oral azithromycin should be encouraged as part of syphilis-control programs in developing countries. Whereas this conclusion would appear to be rational on the basis of the authors' results, we believe that there are other factors that should be considered before opting for such a strategy.

Although the authors acknowledged the potential for the emergence of azithromycin-resistant Treponema pallidum, ongoing monitoring for such resistance, as they suggested, requires molecular-sequencing techniques,2 which are unavailable in most developing countries. . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.